• Compugen’s Cancer Immunotherapy Program Targets TIGIT Immune Checkpoint
  • Merck to Lead Anti-CD27 Antibody into Clinical Testing as Immunotherapy for Cancer
  • Findings on ‘Solid Stress’ in Tumors Could Spark Development of New Therapies
  • Topical Psoriasis Medication May Help Fight Premalignant Skin Lesions, Study Suggests
  • Revolutionary DNA-Editing Technique Tested in Patient for First Time
  • FDA Grants Priority Review to Avelumab for Metastatic Merkel Cell Carcinoma Treatment
  • Collaborative Agreement Struck to Assess Combo Therapy in 8 Tumor Types
  • Juno Halts Clinical Trial of Leukemia Therapy for Second Time This Year
  • T-cell Immunotherapy That Swaps Gene Parts Seen to Avoid Autoimmune Reaction in Mice
  • Targeting Myeloid Cells in Select Tumors May Strengthen Immune Checkpoint Inhibitors
  • Nano-Pulse Stimulation Shows Promise as Potential Anti-Cancer Immunotherapy
  • Compugen Identifies Novel Immune Checkpoint with Potential for the Development of New Cancer Immunotherapies